UBX Unity Biotechnology (NASDAQ) +92.77% intraday 18 Mar 2026: oversold bounce trade

UBX stock jumped 92.77% intraday on 18 Mar 2026, trading at USD 0.2001 on the NASDAQ in the United States. This move came with a volume spike to 3,356,988 shares versus an average of 761,635, a classic sign of an oversold bounce. Traders chasing a rebound should weigh the short-term technical edge against weak fundamentals, including EPS -1.63 and a negative PE. We review the setup, risks, and a clear trade plan for an oversold bounce strategy.